How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia

Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, Luca Laurenti, Roberta Murru, Andrea Visentin, Gianluigi Reda, Francesca Romana Mauro, Giulia Quaresmini, Anna Vanazzi, Candida Vitale, Lorella Orsucci, Massimo Massaia, Alessandro Sanna, Marina Motta, Adalberto Ibatici, Isacco Ferrarini, Chiara Borella, Marzia Varettoni, Monica TaniSara Marinoni, Andrea Ferrario, Giulia Zamprogna, Marco Montillo, Alessandra Tedeschi

Research output: Contribution to journalArticle

Abstract

NA
Original languageEnglish
Pages (from-to)1985-1988
Number of pages4
JournalLEUKEMIA & LYMPHOMA
Volume63
DOIs
Publication statusPublished - 2022

Keywords

  • COVID-19
  • Chronic lymphocytic leukemia
  • Rituximab
  • venetoclax

Fingerprint

Dive into the research topics of 'How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this